You are here

  • Home
  • Archive
  • Volume 81, Issue 5
  • Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?

Article info

Article menu

Download PDFPDF

Correspondence
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?
Free

Authors

  • Philippe Mertz Centre National de Référence des Maladies Systémiques et Autoimmunes Rares Est Sud-Ouest (RESO), Department of Rheumatology, Strasbourg, France PubMed articlesGoogle scholar articles
  • Laurent Arnaud Centre National de Référence des Maladies Systémiques et Autoimmunes Rares Est Sud-Ouest (RESO), Department of Rheumatology, Strasbourg, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Philippe Mertz, Rheumatology Department, CHU Hautepierre, Strasbourg 67000, France; philippe.mertz{at}chru-strasbourg.fr
View Full Text

Citation

Mertz P, Arnaud L
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?
Annals of the Rheumatic Diseases 2022;81:e83.

Publication history

  • Received April 17, 2020
  • Accepted April 18, 2020
  • First published April 27, 2020.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.